Effect of intracarotid etoposide on opening the blood-brain barrier.

M K Spigelman, R A Zappulla, J D Goldberg, S J Goldsmith, D Marotta, L I Malis, J F Holland
{"title":"Effect of intracarotid etoposide on opening the blood-brain barrier.","authors":"M K Spigelman,&nbsp;R A Zappulla,&nbsp;J D Goldberg,&nbsp;S J Goldsmith,&nbsp;D Marotta,&nbsp;L I Malis,&nbsp;J F Holland","doi":"10.1089/cdd.1984.1.207","DOIUrl":null,"url":null,"abstract":"<p><p>The effect of an intracarotid artery infusion of etoposide on blood-brain barrier (BBB) integrity was investigated in a rat model system. The external carotid arteries of Sprague-Dawley rats were catheterized in a retrograde manner. Etoposide in a dose range from 3.0 mg/kg to 22.5 mg/kg was infused into the internal carotid artery by this technique. BBB disruption was evaluated qualitatively by the appearance in the infused hemisphere of the systemically administered dye Evans blue and quantitatively by the ratio of counts of the technetium-labeled chelate of diethylenetriaminepentaacetic acid (99mTc-DTPA) in the infused to the noninfused hemisphere. Evidence of increased BBB permeability was seen at all doses of etoposide. Degree of BBB disruption increased with increasing doses of etoposide. The intracarotid infusion and subsequent BBB disruption were well tolerated. Further clinical trials employing the intracarotid administration of etoposide should be cognizant of the potential for BBB disruption.</p>","PeriodicalId":77686,"journal":{"name":"Cancer drug delivery","volume":"1 3","pages":"207-11"},"PeriodicalIF":0.0000,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/cdd.1984.1.207","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer drug delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/cdd.1984.1.207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16

Abstract

The effect of an intracarotid artery infusion of etoposide on blood-brain barrier (BBB) integrity was investigated in a rat model system. The external carotid arteries of Sprague-Dawley rats were catheterized in a retrograde manner. Etoposide in a dose range from 3.0 mg/kg to 22.5 mg/kg was infused into the internal carotid artery by this technique. BBB disruption was evaluated qualitatively by the appearance in the infused hemisphere of the systemically administered dye Evans blue and quantitatively by the ratio of counts of the technetium-labeled chelate of diethylenetriaminepentaacetic acid (99mTc-DTPA) in the infused to the noninfused hemisphere. Evidence of increased BBB permeability was seen at all doses of etoposide. Degree of BBB disruption increased with increasing doses of etoposide. The intracarotid infusion and subsequent BBB disruption were well tolerated. Further clinical trials employing the intracarotid administration of etoposide should be cognizant of the potential for BBB disruption.

颈动脉内依托泊苷对打开血脑屏障的影响。
在大鼠模型系统中研究了颈动脉内灌注依托泊苷对血脑屏障完整性的影响。采用逆行置管法对Sprague-Dawley大鼠颈外动脉插管。采用该技术将依托泊苷以3.0 ~ 22.5 mg/kg的剂量注入颈内动脉。脑屏障破坏的定性评估是通过系统给药的埃文斯蓝染料在输注半球的外观,定量评估是通过输注与未输注半球中技术标记的二乙烯三胺五乙酸螯合物(99mTc-DTPA)的计数比。所有剂量的依托泊苷均可增加血脑屏障的通透性。血脑屏障的破坏程度随着依托泊苷剂量的增加而增加。颈动脉内灌注和随后的血脑屏障破坏耐受良好。采用颈动脉内给药依托泊苷的进一步临床试验应认识到血脑屏障破坏的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信